Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy-Reference-Cited by-同舟云学术

Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy

Published:2006-01 Issue:5 Volume:66 Page:1019-1021
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Yamagishi S.,Nakamura K.,Matsui T.,Sato T.,Takeuchi M.

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy;Yamagishi;Curr Pharm Des,2005

2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

3. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk complications in patients with type 2 diabetes (UKPDS33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

4. Novel approaches in the treatment of angiogenic eye disease;Wegewitz;Curr Pharm Des,2005

5. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy;Yamagishi;Int J Clin Pharmacol Res,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Glycation End Products: New Clinical and Molecular Perspectives;International Journal of Environmental Research and Public Health;2021-07-06

2. Glycation and HMG-CoA Reductase Inhibitors: Implication in Diabetes and Associated Complications;Current Diabetes Reviews;2019-04-01

3. Analysis of advanced glycation end products in the DHS Mind Study;Journal of Diabetes and its Complications;2016-03

4. Evaluation of diabetic retinopathy in a group of type 2 diabetic pacients;Romanian Journal of Diabetes Nutrition and Metabolic Diseases;2012-01-01

5. Alterations to the Blood–Retinal Barrier in Diabetes: Cytokines and Reactive Oxygen Species;Antioxidants & Redox Signaling;2011-09